Okay, following the last two studies posted, let's end this week as the "CoQ10 week."
Today's study of discussion was a randomized, double-blind, placebo-controlled study involving 45 patients with relapsing-remitting multiple sclerosis (MS). Since MS is a chronic inflammatory disease of the central nervous system, in which higher oxidative stress may contribute to its pathogenesis, the aim of this study was to investigate the effect of CoQ10 supplementation on oxidative stress and antioxidant enzyme activity.
12 weeks of supplementation with CoQ10 at a dose of 500 mg/day was found to
be associated with significant increases in activity of the antioxidant enzyme,
superoxide dismutase (SOD), and decrease in levels of malondialdehyde (a marker
of oxidative stress), as compared to controls.
These results suggest that supplementation with coenzyme Q10 at a dose of
500 mg/d may benefit patients with relapsing-remitting MS.
Short and sweet...don't want to keep you too long at the start of the weekend.
There are only a few of them in the Canadian summer, so get out and enjoy!
So click HERE and subscribe to find out more of what you already Know!
Source: Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis